New tumor spatial mapping tool to assess cancer aggressiveness and personalize treatment
aiFRET quantifies HIF1β/HIF2α and PD-1/PD-L1 interactive states in ccRCC sufferers. The higher panel illustrates the expression of HIF1β/HIF2α. HIF1β is the ...